The Australian elapid snakes are among the most venomous in the world. The inland taipan (Oxyuranus microlepidotus) and the common brown snake (Pseudonaja textilis) have toxicity values that are 50 and 12 times, respectively, that of the Indian cobra [1]. In many cases, the toxicity of these snake venoms arises from the presence of powerful prothrombin-activating proteins, and potent presynaptic and postsynaptic neurotoxins. Other components present in the venoms include phospholipases A 2 , serine proteinase inhibitors, l-amino acid oxidases, and natriuretic peptides, all with a broad range of activities [2]. Thus, Australian snake venoms provide a rich source of molecules with potential as therapeutic agents for a variety of medical conditions, including thrombosis, stroke, and cardiovascular disease.